Inventor · disambiguated record
Jerome Molette
Also filed as: MOLETTE JEROME · MOLETTE JÉRÔME
10 granted patents·18 pending applications·1 citations·filing 2012–2023
78Inventor score
Top patents by PatentIndex Score
28 records- 0172US2024051967A1Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 0267US2023255976A1Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau AggregatesAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 0364US9493451B2Amine derivatives as potassium channel blockersHARVEY ANDREW·Filed 2012·Granted Nov 15, 2016·1 cites·28 claims
- 0462US11684625B2Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregatesAC IMMUNE SA·Filed 2019·Granted Jun 27, 2023·0 cites·12 claims
- 0561US2024101563A1Novel compoundsAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 0659US2025042905A1Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 0759US2025034149A1Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 0859US2024034735A1Novel compoundsAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 0958US11623931B2Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2020·Granted Apr 11, 2023·0 cites·10 claims
- 1058US2025018068A14h-imidazo[1,5-b]pyrazole derivatives for diagnosisAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 1156US11814378B2Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregatesAC IMMUNE SA·Filed 2020·Granted Nov 14, 2023·0 cites·32 claims
- 1255US10835624B2Compounds for imaging Tau protein aggregatesAC IMMUNE SA·Filed 2017·Granted Nov 17, 2020·0 cites·14 claims
- 1354US9914702B2Amine derivatives as potassium channel blockersBIONOMICS LTD·Filed 2016·Granted Mar 13, 2018·0 cites·7 claims
- 1454US2018273476A1Amine derivatives as potassium channel blockersBIONOMICS LTD·Filed 2018·Application pending·0 cites
- 1550US11306089B2Gamma-carboline compounds for the detection of Tau aggregatesAC IMMUNE SA·Filed 2019·Granted Apr 19, 2022·0 cites·31 claims
- 1650US10865207B2Compounds for imaging Tau protein aggregatesAC IMMUNE SA·Filed 2017·Granted Dec 15, 2020·0 cites·26 claims
- 1749US2021252175A1Novel compounds for diagnosisAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 1848US12202840B2Compounds for the treatment or alleviation of disorders associated with Tau aggregatesAC IMMUNE SA·Filed 2019·Granted Jan 21, 2025·0 cites·13 claims
- 1948US2019071450A1Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2017·Application pending·0 cites
- 2048US2022378801A1Novel compoundsAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 2147US2023250070A1Dihydrooxazole and thiourea derivatives modulating the nlrp3 inflammasome pathwayAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 2246US2015299184A1Amine Derivatives as Potassium Channel BlockersBIONOMICS LTD·Filed 2015·Application pending·0 cites
- 2346US2021041447A1Azacarboline compounds for the detection of tau aggregatesAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2446US2021047327A1Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnosticsAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2541US9403835B2Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulatorsMERCK PATENT GMBH·Filed 2012·Granted Aug 2, 2016·0 cites·19 claims
- 2640US2021038747A1Novel method of preparing an imaging compoundAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2734US2018264146A1Novel imaging compoundsAC IMMUNE SA·Filed 2016·Application pending·0 cites
- 2834US2015274657A1PyrrolidinesMERCK PATENT GMBH·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerome Molette files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →